ConsumerAffairs2d
FTC sues Evoke Wellness, claiming it misled consumers seeking substance abuse treatment
The Federal Trade Commission (FTC) has filed a lawsuit against Evoke Wellness, LLC, Evoke Health Care Management, and their ...
Nasdaq26d
Evoke Pharma Addresses FDA Update on Domperidone Supply and Highlights GIMOTI as the Only Approved Treatment for Gastroparesis
Evoke Pharma, Inc. announces its commitment to addressing the needs of patients with gastroparesis following the FDA's update indicating that the supply of unapproved domperidone, used ...
Women's Health23d
What is HIFU? The non-invasive, jaw-tightening treatment celebrities swear by
Heralded by celebrities, this non-invasive treatment has been making waves in the beauty industry for the last couple of years. Promising tighter skin and a more defined jawline without needles or ...
Business Insider27d
Evoke Pharma Highlights GIMOTI as a Leading Solution for Gastroparesis Treatment as Domperidone Supply Ends
Matt D’Onofrio, CEO of Evoke Pharma, commented, “FDA’s recent announcements highlight the critical need for reliable treatment options for patients. We believe GIMOTI addresses many needs of ...
Yahoo Finance27d
Evoke Pharma Highlights GIMOTI as a Leading Solution for Gastroparesis Treatment as Domperidone Supply Ends
Dec. 19, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ ... As the sole FDA-approved nasal spray treatment for acute and recurrent diabetic gastroparesis in adults, GIMOTI® (metoclopramide ...
Stockhouse26d
Evoke Pharma Highlights GIMOTI as a Leading Solution for Gastroparesis Treatment as Domperidone Supply Ends
CloseCurlyDoubleQuote; Matt D’Onofrio, CEO of Evoke Pharma, commented, “FDA’s recent announcements highlight the critical need for reliable treatment options for ...